InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Bartram Richard, 首席财务官. Officer active across 2 companies, notably Esperion Therapeutics, Inc.. Aggregated, 3 reports have been logged. Activity tracked since 29 October 2021. The latest transaction was filed on 2 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bartram Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
15,000 股0Common StockSEC:0001193125-26-035584:0
37,000 股0Common StockSEC:0001628280-22-006408:0
18,700 股0Common StockSEC:0001628280-21-021008:0
3 条申报中的 3 条
About Bartram Richard
Richard Bartram is the Chief Financial Officer at Esperion Therapeutics, Inc. He is responsible for managing the company's finances, including accounting, financial planning, and financial reporting.
